Form CORRESP - Correspondence:
SEC Accession No. 0001193125-23-296750
Filing Date
2023-12-15
Accepted
2023-12-15 16:54:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 17702
2 GRAPHIC g496651g1215042851739.jpg GRAPHIC 3337
  Complete submission text file 0001193125-23-296750.txt   23413
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)